StockWatch
·
Pharmaceuticals
Board Meeting3 Aug 2026, 05:20 pm

Ind-Swift Laboratories Board Meeting on Aug 10 to Approve Financial Results

AI Summary

Ind-Swift Laboratories Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item for this meeting is to consider, approve, and take on record the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The company has also confirmed that prior notification regarding the trading window closure was issued on June 26, 2026. Further details are available on the company's website.

Key Highlights

  • Board meeting scheduled for August 10, 2026.
  • To approve Un-Audited Standalone and Consolidated Financial Results.
  • Results pertain to the quarter ended June 30, 2026.
  • Trading window closure information previously communicated.